William Peterson: Okay. Yeah, that makes sense. So I want to come back to the last question for me coming back to I think it was Mike’s question on sort of use of cash. Can you just explicitly lay out how we should think about things like OpEx trajectory? Anything notable on CapEx one timers and then the legal fees, I guess, going forward? I mean, I think investors really would want to understand how the use of cash and cash burn looks through the balance of the year and potentially in the next year.
Parker Meeks: Great questions. I’ll pass it to Jiajia for that.
Jiajia Wu: Thank you, Bill. Yeah, as I mentioned earlier, right, we’re looking at our expenses for the last 15 to 18 months. We incurred a significant amount of legal expense. And then as I just stated earlier, right. Special committee concludes its investigation and our repayment has gone. And those additional I’ll call accounting and auditing fee won’t be recurring. They’re looking at, you know, one another item I mentioned is the auto business combination cancellation. So that expense is cash and inventory. That’s 8.5. So that’s non-recurring. But I think the focus point, as I said in my opening remark, is cash management. And we’re very focused on food and cash management. And we have taken, you know and taken steps and plan to take additional steps to improve our cost structure, right.
And our focus as I said earlier is around our R&D and fuel cell R&D and invest not only from the personnel and also invest from our manufacturing line in Bolingbrook, Illinois. So we would expect our R&D cost in 2023 will be comparable if the commodity price of hydrogen stays the same. And, yeah, we’re not slowing down our R&D in fuel cell technology. So as we looking at our spend going forward and we are very focused on how to deploy our vehicle platforms and we focus on our anchor customers and we develop our — yeah we develop our cash use case or models around our anchor customers and how to go to market, commercialize our vehicles, you know, and turn our working capital in a timely fashion. So those are couple you know just a highlights.
I would refer you to the details back to our MD&A discussions included in our Q1 2023 Form 10-Q.
Parker Meeks: Yeah, Bill, I’ll just add to that. So if you look at some of the major cost items. Jiajia gave a view on R&D, on CapEx. We gave a view on ’23. If you look at the past, the 200 kilowatt SOP, which is 2024, it’s less than 10 million of CapEx left to get that SOP, right. So this is not a CapEx heavy area in terms of fuel cell stack and system assembly. The MEA line that we have that’s already producing, it’s on a path to commissioning. That line we’re comfortable can once this SOP can scale to considerable capacity and supply what we need over the coming several years as we debottleneck that over time. So the CapEx left in the fuel cell plant is really around single cell stack and assembly automation quality installs of camera technology, etcetera.
